ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters.

@article{Waldmann2003ABCsOR,
  title={ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters.},
  author={Thomas A. Waldmann},
  journal={Leukemia & lymphoma},
  year={2003},
  volume={44 Suppl 3},
  pages={S107-13}
}
Although the introduction of the monoclonal antibody rituximab 5 years ago led to a marked improvement in the treatment of non-Hodgkin's lymphoma (NHL), most patients do not experience a complete response to therapy, and many who do respond relapse. One way of improving the efficacy of monoclonal antibodies is to use them to deliver cytotoxic agents, such… CONTINUE READING